Cetuximab, Fluorouracil, and Irinotecan

About

Membership operator: AND

Therapies: 3

Therapies

Cetuximab (tx:ncit:C1723)

Fluorouracil (tx:ncit:C505)

Irinotecan (tx:ncit:C62040)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy group.

Organizations
Biomarkers
Cancer types
Therapies
Organizations Biomarkers Cancer types Therapies
FDA (2) EGFR positive, Wild type KRAS Colorectal Adenocarcinoma Cetuximab, Fluorouracil, Irinotecan